Medical Devices Spain

Spain Intragastric Balloon Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Spain Intragastric Balloon Market Industry Trends and Forecast to 2034: Segmented by (Type, Filling, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Spain · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $5.9 Mn Placeholder estimate
Estimate 2025 $6.5 Mn 2.1% of the global market
Projected 2034 $15.0 Mn 130.1% Adds $8.5 Mn over 9 forecast years
CAGR 2025–2034 9.7% Faster than 65% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • Spain is 2.11% of the global market.
  • In Europe, the largest is Germany at $9.7 Mn.
  • Fastest growing: Russia at 11% a year.
  • Spain ranks 5th of 6 by size in Europe.

Market size projection

Spain

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$8.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Intragastric Balloon Market market size by year, Spain
YearMarket sizeChange that yearSince 2025
2024 (estimate) $5.9 Mn — —
2025 (base) $6.5 Mn +$0.6 Mn —
2026 (forecast) $7.1 Mn +$0.6 Mn +9.7%
2027 (forecast) $7.8 Mn +$0.7 Mn +20.3%
2028 (forecast) $8.6 Mn +$0.8 Mn +32%
2029 (forecast) $9.4 Mn +$0.8 Mn +44.8%
2030 (forecast) $10.3 Mn +$0.9 Mn +58.9%
2031 (forecast) $11.3 Mn +$1.0 Mn +74.3%
2032 (forecast) $12.4 Mn +$1.1 Mn +91.2%
2033 (forecast) $13.6 Mn +$1.2 Mn +109.7%
2034 (forecast) $15.0 Mn +$1.3 Mn +130.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Spain Intragastric Balloon Market Analysis at a glance
Market size, 2025$6.5 Mn placeholder estimate
Forecast, 2034$15.0 Mn placeholder estimate
Growth (CAGR), 2025–20349.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, filling and end user (see all)
Key playersAllurion Technologies, Apollo Endosurgery, Spatz Medical, Obalon Therapeutics, Helioscopie (see all)
Regulator in SpainAEMPSSource: Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
Active clinical trials1 in SpainSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Spain. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Spain Intragastric Balloon Market Analysis Executive Summary

Intragastric balloons are soft balloons placed in the stomach for a few months to help people eat less and lose weight without surgery.

Key segments of the intragastric Balloon market include type (Single Balloon, Dual Balloon and Swallowable Balloon) and filling (Saline-Filled and Gas-Filled).

Bar chart: Spain Intragastric Balloon market size, 2024–2034, placeholder estimates. $5.9 Mn in 2024, $6.5 Mn in 2025 and $15.0 Mn in 2034, 9.7% CAGR.
Spain Intragastric Balloon market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Spain Intragastric Balloon Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the intragastric Balloon market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the intragastric Balloon market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the intragastric Balloon market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Intragastric Balloon Market in Spain

The intragastric Balloon market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Intragastric Balloon Market in Spain

Intragastric Balloon in Spain: rules, payment and research

Medical devices need CE marking under the EU Medical Device Regulation (MDR); AEMPS, the Spanish Agency of Medicines and Medical Devices, oversees them in Spain.⁠[1] The National Health System (SNS), run by the regions, gives universal public care.⁠[2] ClinicalTrials.gov lists 1 study on Intragastric Balloon that is recruiting, active or about to start in Spain.⁠[3] Obesity (adults): 15.3% of adults in 2024, the latest WHO figure for Spain.⁠[4]

[1] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.

[2] Spanish Ministry of Health. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Spain. Retrieved 12 Nov 2026.

[4] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how intragastric Balloon products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Spain.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Intragastric Balloon right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Intragastric Balloon in context

Spain compared

  • Obesity (adults): 15.3% of adults (2024). World: 16.2% of adults (2024). 4th highest of the 6 countries we cover in Europe.[1]
  • Health spending per person: 3,107 US$ per person (2023). World: 1,317 US$ per person (2023). 5th highest of the 6 countries we cover in Europe.[2]
  • Doctors: 4.29 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 6 countries we cover in Europe.[3]

[1] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 17 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Intragastric Balloon market in Spain?
Placeholder estimate: about $6.5 Mn in 2025, rising to about $15.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Intragastric Balloon market in Spain growing?
Placeholder estimate: about 9.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Intragastric Balloon market report cover?
The report splits the market by type (Single Balloon, Dual Balloon, Swallowable Balloon), filling (Saline-Filled, Gas-Filled) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Intragastric Balloon market?
Key players include Allurion Technologies, Apollo Endosurgery, Spatz Medical, Obalon Therapeutics and Helioscopie.
What is driving the Intragastric Balloon market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the intragastric Balloon market.
Who regulates Intragastric Balloon in Spain?
Medical devices need CE marking under the EU Medical Device Regulation (MDR); AEMPS, the Spanish Agency of Medicines and Medical Devices, oversees them in Spain. Source: Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
How is healthcare paid for in Spain?
The National Health System (SNS), run by the regions, gives universal public care. Source: Spanish Ministry of Health. Checked 14 Nov 2026.
How many clinical trials on Intragastric Balloon are running in Spain?
1 study is recruiting, active or about to start in Spain, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Spain. Retrieved 12 Nov 2026.
What does WHO report for Spain?
Obesity (adults): 15.3% of adults in 2024, the latest WHO figure. Source: WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 15 Nov 2026.
How many people in Spain are 65 or older?
21.6% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 17 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Spain

See all

Related on obesity and diabetes

See the topic